ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 212.50
+5.50 (2.66%)
Oct 8, 2026, 1:59 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 15.09 billion as of October 8, 2026. It is the 15,228th most valuable company in the world and the 550th biggest in Taiwan. Its market cap has increased by 240.92% in one year.
Market Cap
15.09B
Enterprise Value
14.21B
Revenue
52.76M
Global Rank
Country Rank
#550 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 15.09B, an increase of 1,423.23%. That is a compound annual growth rate of 68.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 15.09B | 273.46% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 23.06B |
| Sunmax Biotechnology | 21.57B |
| Medigen Vaccine Biologics | 20.38B |
| TaiMed Biologics | 16.72B |
| Ever Supreme Bio Technology | 16.27B |
| EirGenix | 15.32B |
| Gongwin Biopharm Holdings | 14.41B |
| Lumosa Therapeutics | 13.62B |